3D InSight™ Liver Disease Platform
Imagine the intricate nature of liver-disease biology condensed into hundreds of 3D microtissues, providing you with data and insights that exponentially accelerate your research. This is InSphero's NASH (MASH) and NAFLD (MASLD) platform.
Benefit from our market-leading in vitro models for liver disease drug discovery, empowering you to achieve more with a controlled, scalable, biologically relevant, and cost-effective screening platform for new drugs. These 3D liver models facilitate studies of disease mechanisms, enable early assessment of drug safety and efficacy, and accurately simulate human liver pathology. Enhance your ability to predict human responses, reduce the chances of late-stage clinical failures, expedite the drug discovery process, and preserve valuable resources for your team with the 3D InSight™ Liver Disease Platform.
Why Liver Disease with InSphero?
Your Success is Our Mission
Schedule a consultation with our experts